Rep. Tom Price (R-GA), President-elect Donald Trump’s nominee to head the Department of Health and Human Services, admitted that he decided to buy stock in an Australian biotech firm after receiving information from Rep. Chris Collins (R-NY), a board member of that company, the Huffington Post reports.
“Ethics experts stated that Price could be in violation of the STOCK Act, a bipartisan 2012 law that bans insider trading by members of Congress.”
?Political Trivia
Eight moments in political history. Put them on a timeline.
Play →
Five senators. Three bills. Can you guess how they all voted?
Play →
Nine Justices. One case. How did they rule?
Play →
Do you have your finger on the pulse of America?
Play →
Four questions a day.
Play →
A new game every day.